Rhode Island Multistate Pharmacy Jurisprudence (MPJE) Practice Exam

Disable ads (and more) with a membership for a one time $2.99 payment

Study for the Rhode Island Multistate Pharmacy Jurisprudence Exam. Access multiple choice questions, hints, and detailed explanations. Prepare effectively for your exam!

Each practice test/flash card set has 50 randomly selected questions from a bank of over 500. You'll get a new set of questions each time!

Practice this question and more.

Which medications can be prescribed for addiction treatment outside of a treatment program by a DATA-waived prescriber?

Methadone
Suboxone® and Subutex®
Buprenorphine only
Oxycodone

The correct answer is: Suboxone® and Subutex®

Suboxone® and Subutex®, which contain buprenorphine, are approved for treating opioid addiction and can be prescribed outside of a formal treatment program by prescribers who have obtained a waiver under the Drug Addiction Treatment Act (DATA). These medications are specifically designed to help manage opioid dependency by alleviating withdrawal symptoms and reducing cravings, making them effective options for outpatient treatment. Engaging with these medications requires a prescriber to have specific training and a waiver, which allows them to provide treatment responsibly. Unlike methadone, which can only be prescribed within certified treatment centers and requires more stringent controls, or oxycodone, which is a Schedule II controlled substance primarily used for pain management but not indicated for addiction treatment, Suboxone® and Subutex® are tailored for addiction recovery under appropriate circumstances. Buprenorphine alone, while an essential component of Suboxone® and Subutex®, is not available as a standalone prescription for addiction treatment outside of these formulations in the context provided. This comprehensive approach ensures both safety and efficacy in treating individuals with opioid use disorder.